On 8 February 2019, the World Trade Organization (WTO) published a submission (IP/C/W/652) by Australia; Canada; Chile; The European Union; Hong Kong, China; Japan; the Republic of Korea; Singapore; Switzerland; Chinese Taipei; and the United States to the TRIPS Council… Continue Reading
On Thursday February 7, 2019, KEI submitted comments and intent to testify at the hearing for the 2019 US Trade Representative’s Special 301 review process. This year’s hearing will take place on Wednesday February 27, 2019 at the Office of… Continue Reading
On 1 February 2019, the World Trade Organization (WTO) published a submission (IP/C/W/651) by South Africa to the TRIPS Council on Intellectual Property and the Public Interest: Promoting Public Health Through Competition Law and Policy. The South African paper endeavors… Continue Reading
Knowledge Ecology International (KEI) delivered the following intervention on the WHO Cancer report (agenda item 5.7.2) on Tuesday evening, 29 January 2019. We commend the WHO secretariat for the 171-page report on “Pricing of cancer medicines and its impacts.” A… Continue Reading
Knowledge Ecology International (KEI) delivered the following statement on the WHO roadmap on access to medicines, vaccines and health products (agenda item 5.7.1) on Tuesday evening, 29 January 2019 during the 144th session of WHO’s Executive Board. The WHO Roadmap… Continue Reading
Knowledge Ecology International (KEI) will make the following intervention on agenda item 5.5.3 titled “Preparation for the high-level meeting of the General Assembly on universal health coverage.” Currently, WHO member states are involved in intense negotiations on a draft resolution… Continue Reading
Attached are the slides from a presentation in Rome at the Agenzia Italiana Del Farmaco (AIFA) for a workshop on CAR-T in operation: Challenges and Perspectives. James.Love.KEI.CART.Rome.24Jan2019-final
On 18 December 2018, the World Health Organization (WHO) published a “Technical report on Pricing of cancer medicines and its impacts” (hereinafter referred to as the “WHO Cancer Report”). The mandate for the WHO Cancer Report emanates from operative paragraph… Continue Reading
KEI filed this today, regarding a Federal Register request for comments (83 FR 57790) on the negotiating objectives for a U.S./UK trade agreement. KEI-US-UK-15Jan2019-statement-request2testify
KEI filed comments on the NIST Draft Green paper on the return from investment on federally funded R&D (See: https://www.keionline.org/29518). We expect the comment period to be extended, but filed this on January 9, 2018, as an initial submission. KEI-comments-NIST-SP-1234-ROI-9Jan2018… Continue Reading